PHARMACY AND MEDICINE IN LABANON: THE MANY OPPORTUNITIES TO LEARN
Journal: Ekonomické trendy (Vol.1, No. 3)Publication Date: 2016-08-20
Authors : Zh. V. Mironenkova; M. AL Moussawi; A. F. Davletianova;
Page : 27-30
Keywords : Business Monitor International (BMI); sales over the country; pharmaceutical sector; health care market;
Abstract
This article observes the development of sales in Lebanon and shows what factors affect sales and whether there is other, how good are Business Monitor International's reports? Lebanese population refers to the pharmacist like a doctor; the government is reducing the price of medication to allow higher access for the population and to alleviate the burden on public finances. The Lebanese pharmaceutical market is 95 % dependent on finished pharma- ceuticals. Pharmaceutical per capita spending to increase further from $279 in 2015 to $374 in 2016. As the large spending and prioritization of medicine in Lebanon is likely to drive mar- ket growth, some hindering elements might come into play. Lebanon's proximity to war- plagued Syria will negatively affect pharmaceutical trade relations. The poor regulatory envi- ronment and the loose enforcement of rules are also likely to limit growth prospects
Other Latest Articles
- WAYS OF PROFITABILITY INCREASE OF BATH-AND-LAUNDRY COMPLEXES IN THE REGIONAL MARKET OF CONSUMER SERVICES
- THE APPROACHES TO THE USE OF SPATIAL DEVELOPMENT INDICATORS IN THE ANALYSIS AND FORECASTING OF SOCIAL AND ECONOMIC DEVELOPMENT IN THE RUSSIAN SCIENCE
- THE CONCEPT, THE ADVANTAGES AND DISADVANTAGES OF ALTERNATIVE METHODS OF SOLUTION ECONOMIC DISPUTES
- FORMATION MANAGEMENT STRATEGY OF LARGEST INDUSTRIAL ENTERPRISE AIMED AT ENVIRONMENTAL RESPONSIBILITY OF BUSINESS
- NICOLAE IORGA ABOUT THE HOHENZOLLERNS
Last modified: 2016-12-26 16:18:31